What You Should Know:
– Paige, a provider of AI-powered pathology solutions, today announced a significant expansion of Paige PanCancer Detect, its groundbreaking cancer detection tool.
– Originally launched in 2024 with the ability to identify cancer in 17 tissue types, PanCancer Detect now supports over 40 tissue and organ types, thanks to advancements in Paige’s AI foundation models.
AI-Powered Pathology Solution Enhances Diagnostic Accuracy and Efficiency
This expanded capability has been made possible by Virchow V2, one of Paige’s state-of-the-art foundation models trained on an unprecedented dataset of 3 million digitized slides and 1.8 billion parameters. This vast dataset enables PanCancer Detect to accurately identify cancerous tissue across a wider range of samples, improving diagnostic accuracy and efficiency in pathology labs.
Key benefits of Paige PanCancer Detect:
- Enhanced Efficiency: Automates cancer detection, allowing pathologists to prioritize critical cases and reduce turnaround time.
- Improved Accuracy: AI-powered analysis helps to identify subtle cancerous changes that may be missed by human review.
- Quality Control: Flags potential diagnostic discrepancies, minimizing errors and improving the quality of diagnoses.
- Reduced Resource Constraints: Helps alleviate staffing shortages and workload pressures in pathology labs.
Proven Performance
The initial version of Paige PanCancer Detect has been independently validated in a study assessing 62 challenging cases across 16 tissue types. The study demonstrated the software’s strong performance in identifying cancerous slides, paving the way for its clinical application as a multi-organ screening tool.
Expanding Accessibility
Paige PanCancer Detect is currently available through Paige’s FullFocus image viewer and will soon be accessible through the company’s platform partners, including PathPresenter, Aiforia, Indica Labs, PathAI, and Gestalt. This expanded accessibility will enable more pathology labs to benefit from this innovative AI solution.“By leveraging the tissue-agnostic capabilities of Virchow V2, Paige PanCancer Detect transforms cancer detection into a broad, scalable AI solution that generalizes the concept of ‘cancer’ across tissues,” said Siqi Liu, Director of AI Science at Paige. “This unique approach, originally demonstrated in our research published in Nature Medicine, has shown in our studies to be effective in detecting both rare cancer variants, low-prevalence cancers, and even precancerous lesions—challenges that traditional task-specific AI models often struggle to address.”
